US2015307586A1PendingUtilityA1
Epsigam fusion protein
Est. expiryApr 2, 2034(~7.7 yrs left)· nominal 20-yr term from priority
C07K 16/00C07K 14/70535C07K 2319/70C07K 14/7056C07K 16/2851C07K 2317/52Y10S424/81Y10S424/805C07K 2319/30
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Epsi-gam provides a novel fusion protein with the ability to cross-link either of the FcεRI or FcεRII cell surface receptors with an FcγRIIb cell surface receptor in order to block IgE-mediated biological responses.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for manufacturing a fusion protein, comprising
synthesizing a nucleotide sequence comprising of a first restriction site at a first end of the nucleotide sequence and a second restriction site at a second end of the nucleotide sequence; inserting the nucleotide sequence into a cloning vector; excising the nucleotide sequence from the cloning vector using a first restriction enzyme corresponding to said first restriction site and a second restriction enzyme corresponding to the second restriction site; inserting the nucleotide sequence into an expression vector, wherein said expression vector links the expression of an exogenous protein to the glutamine synthetase gene; transfecting cells with the expression vector using electroporation, wherein the cells are deficient in glutamine synthetase; incubating the transfected cells; and collecting a secreted protein from the cells comprising said fusion protein.
2 . The method of claim 1 , wherein the nucleotide sequence comprises the sequence of SEQ ID: 1.
3 . The method of claim 2 , wherein the nucleotide sequence is synthesized using gene synthesis techniques.
4 . The method of claim 1 , wherein the first restriction site and the second restriction site are restricted by the same restriction enzyme.
5 . The method of claim 1 , wherein the first restriction site comprises a Hind III site, and the second restriction site comprises an EcoRI site.
6 . The method of claim 1 , wherein the first restriction enzyme comprises HindIII and the second restriction enzyme comprises EcoRI.
7 . The method of claim 1 , wherein the cloning vector comprises pUC57.
8 . The method of claim 1 , wherein the cells comprise Chinese Hamster ovary cells.
9 . The method of claim 1 , wherein electroporation comprises delivering a single pulse at about 300V and 900 uF with resistance set to infinity.
10 . The method of claim 1 , wherein the cells are incubated at 5% CO2 in a 37 C incubator.
11 . The method of claim 1 , wherein the fusion protein comprises the sequence of SEQ ID: 2.Join the waitlist — get patent alerts
Track US2015307586A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.